These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3413717)

  • 41. Failure of aspirin and diltiazem to prevent the formation of acute coronary thrombi in dogs.
    Morishima Y; Tanaka T; Watanabe K; Shibutani T; Takahashi M; Shibano T
    Methods Find Exp Clin Pharmacol; 1995 May; 17(4):273-7. PubMed ID: 7475514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
    Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
    Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition by nitroglycerin of canine platelet aggregation and cyclic flow reductions in stenosed coronary arteries.
    Tanaka T; Morishima Y; Watanabe K; Takahashi M; Shibano T
    Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):693-700. PubMed ID: 9053590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Free oxygen radicals contribute to platelet aggregation and cyclic flow variations in stenosed and endothelium-injured canine coronary arteries.
    Ikeda H; Koga Y; Oda T; Kuwano K; Nakayama H; Ueno T; Toshima H; Michael LH; Entman ML
    J Am Coll Cardiol; 1994 Dec; 24(7):1749-56. PubMed ID: 7963124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo inhibition of platelet aggregation and occlusive coronary thrombus formation by a new calcium antagonist (R023-6152).
    Sordahl LA; Rex KA; Benedict CR
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):504-10. PubMed ID: 1724526
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathological basis of failure of concurrent glyceryl trinitrate therapy to improve efficacy of tissue type plasminogen activator in coronary thrombosis.
    Nicolini FA; Nichols WW; Saldeen TG; Mehta JL
    Cardiovasc Res; 1991 Apr; 25(4):283-9. PubMed ID: 1909212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction between the effects of 5-hydroxytryptamine and adrenaline on the growth of platelet thrombi in the coronary artery of the anaesthetized dog.
    McAuliffe SJ; Snow HM; Cox B; Smith CC; Noble MI
    Br J Pharmacol; 1993 Jun; 109(2):405-10. PubMed ID: 8358542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Possible platelet thrombi formation in dog and human femoral arteries.
    Folts JD; Detmer DE; Nadler R
    Tex Heart Inst J; 1982 Mar; 9(1):19-26. PubMed ID: 15226806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Problem with aspirin as antithrombotic agent in coronary artery disease.
    Folts JD; Rowe GG; Rao GH
    Lancet; 1988 Apr; 1(8591):937-8. PubMed ID: 2895855
    [No Abstract]   [Full Text] [Related]  

  • 50. Exacerbation of acute platelet thrombus formation in stenosed dog coronary arteries with smoke from a non-tobacco-burning cigarette.
    Gering SA; Folts JD
    J Lab Clin Med; 1990 Nov; 116(5):728-36. PubMed ID: 2230543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
    Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of thrombus formation by endothelin-1 in canine models of arterial thrombosis.
    Leadley RJ; Humphrey WR; Erickson LA; Shebuski RJ
    Thromb Haemost; 1995 Dec; 74(6):1583-90. PubMed ID: 8772241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liposome-bound prostaglandin E1 often prevents cyclic flow variations in stenosed and endothelium-injured canine coronary arteries.
    Willerson JT; Yao SK; McNatt J; Cui K; Anderson HV; Swensen C; Ostro M; Buja LM
    Circulation; 1994 Apr; 89(4):1786-91. PubMed ID: 8149544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A monoclonal antibody against the platelet glycoprotein IIb/IIIa receptor complex prevents platelet aggregation and thrombosis in a canine model of coronary angioplasty.
    Bates ER; McGillem MJ; Mickelson JK; Pitt B; Mancini GB
    Circulation; 1991 Dec; 84(6):2463-9. PubMed ID: 1659954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High dose intravenous aspirin, not low dose intravenous or oral aspirin, inhibits thrombus formation and stabilizes blood flow in experimental coronary vascular injury.
    Mickelson JK; Hoff PT; Homeister JW; Fantone JC; Lucchesi BR
    J Am Coll Cardiol; 1993 Feb; 21(2):502-10. PubMed ID: 8426017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of cigarette smoke and nicotine on platelets and experimental coronary artery thrombosis.
    Folts JD; Gering SA; Laibly SW; Bertha BG; Bonebrake FC; Keller JW
    Adv Exp Med Biol; 1990; 273():339-58. PubMed ID: 2288288
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries.
    Anderson HV; McNatt J; Clubb FJ; Herman M; Maffrand JP; DeClerck F; Ahn C; Buja LM; Willerson JT
    Circulation; 2001 Nov; 104(19):2331-7. PubMed ID: 11696474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dispersion of coronary artery thrombi by antagonism of platelet serotonin receptor in the dog.
    Belcher PR; Drake-Holland AJ; Hynd J; Noble MI
    Cardiovasc Res; 1992 Mar; 26(3):292-6. PubMed ID: 1423425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The snake venom peptide sarafotoxin S6b inhibits repetitive platelet thrombus formation in the stenosed canine coronary artery.
    Leadley RJ; Lee P; Erickson LA; Shebuski RJ
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S199-203. PubMed ID: 7509944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antithrombotic effects of a platelet fibrinogen receptor antagonist in a canine model of carotid artery thrombosis.
    Willette RN; Sauermelch CF; Rycyna R; Sarkar S; Feuerstein GZ; Nichols AJ; Ohlstein EH
    Stroke; 1992 May; 23(5):703-11. PubMed ID: 1605806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.